|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/08 | |
| A61K 47/26 | |||
| A61K 47/38 | |||
| A61K 9/16 | |||
| A61K 31/55 |
| (11) | Number of the document | 2961383 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14712793.0 |
| Date of filing the European patent application | 2014-02-28 | |
| (97) | Date of publication of the European application | 2016-01-06 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2014/055890 |
| Date | 2014-02-28 |
| (87) | Number | WO 2014/133196 |
| Date | 2014-09-04 |
| (30) | Number | Date | Country code |
| 2013041105 | 2013-03-01 | JP |
| (72) |
AKAGI, Akitsuna, JP
SUZUKI, Kai, JP
NAKAMURA, Atsuya, JP
NISHIBAYASHI, Toru, JP
|
| (73) |
Otsuka Pharmaceutical Co., Ltd.,
9, Kanda-Tsukasamachi 2-chome Chiyoda-ku, Tokyo 101-8535,
JP
|
| (54) | SUSPENSION FOR ORAL ADMINISTRATION COMPRISING AMORPHOUS TOLVAPTAN |
| SUSPENSION FOR ORAL ADMINISTRATION COMPRISING AMORPHOUS TOLVAPTAN |